Includes bibliographical references and index.

Monitoring of anticoagulant therapy and patients being treated with warfarin -- Monitoring of anticoagulant therapy in patients being treated with unfractionated heparin -- Monitoring of anticoagulant therapy in patients being treated with low molecular weight heparin -- Monitoring of anticoagulant therapy in patients being treated with fondaparinux -- Monitoring of anticoagulant therapy in patients being treated with lepirudin or argatroban -- Evaluation for heparin induced thrombocytopenia -- Evaluation of prolongations of the PT and the PTT, and assessment for deficiencies of coagulation factors -- Evaluation for disseminated intravascular coagulation -- Evaluation for a congenital hypercoagulable state -- Evaluation for antiphospholipid antibodies -- Evaluation for von Willebrand disease -- Evaluation for a coagulation factor VIII inhibitor -- Evaluation for thrombocytopenia that is not associated with heparin exposure -- Evaluation for platelet dysfunction in the presence or absence of antiplatelet agents.